Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.

about

Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.

Item

http://www.wikidata.org/entity/Q47162938

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Molecular changes in premenopa ...... mese women after oophorectomy.

@en

Molecular changes in premenopa ...... mese women after oophorectomy.

@nl

type

Item

label

Molecular changes in premenopa ...... mese women after oophorectomy.

@en

Molecular changes in premenopa ...... mese women after oophorectomy.

@nl

prefLabel

Molecular changes in premenopa ...... mese women after oophorectomy.

@en

Molecular changes in premenopa ...... mese women after oophorectomy.

@nl

P1476

Molecular changes in premenopa ...... mese women after oophorectomy.

@en

P2093

Ben P Haynes

http://www.w3.org/2001/XMLSchema#string

Elizabeth Folkerd

http://www.w3.org/2001/XMLSchema#string

Ian E Smith

http://www.w3.org/2001/XMLSchema#string

Le Hong Quang

http://www.w3.org/2001/XMLSchema#string

Maria Afentakis

http://www.w3.org/2001/XMLSchema#string

Mark Clemons

http://www.w3.org/2001/XMLSchema#string

Nguyen Van Dinh

http://www.w3.org/2001/XMLSchema#string

Ophira Ginsburg

http://www.w3.org/2001/XMLSchema#string

Pham Hong Khoa

http://www.w3.org/2001/XMLSchema#string

Pham Thi Han

http://www.w3.org/2001/XMLSchema#string

P2860

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Progesterone receptor modulates ERα action in breast cancer.

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.

Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole

Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-bas

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases

Molecular response to aromatase inhibitor treatment in primary breast cancer.

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.

P2888

s41523-017-0049-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41523-017-0049-Z

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mitch Dowsett

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214214

http://www.w3.org/2001/XMLSchema#string

P932

5703856

http://www.w3.org/2001/XMLSchema#string